Cenevo has launched two AI agents for lab workflow automation, aiming to cut manual work and implementation costs by up to 50%, according to the company. The agents support protocol digitization and no-code workflow generation.
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
New Labcorp survey of 152 oncologists reveals 89% expect care to become more complex within three years, while digital integration and coverage barriers persist.
HighRes and Opentrons have partnered to develop AI agent-to-agent lab automation, integrating robotic platforms and orchestration software to enable autonomous workflows using natural language input. A live demo is planned for SLAS 2026.
Ambry Genetics supported a new study evaluating 6,718 PALB2 gene variants using MAVEs, advancing risk assessment for hereditary breast and pancreatic cancer.
